Revolution Medicines, Inc.
RVMDW· Nasdaq
RVMDWRevolution Medicines, Inc.
Quarterly figures for Revolution Medicines, Inc., with source filings when available.
23 quarters. Mar 31, 2019 to Jun 30, 2026. USD.
Revolution Medicines, Inc. has filed its 10-Q within 36 to 38 days of period end across its last 8 quarters. The 10-K runs 56 to 90 days.
Revolution Medicines, Inc. · CIK 1628171 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 5, 2026 · after-hours | Aug 5, 2026 | 36 d | 10-Q | — | — | -$3.06 | |
| Mar 31, 2026 |
| May 6, 2026 · after-hours |
| May 6, 2026 |
| 36 d |
| 10-Q |
| — |
| — |
| -$2.29 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Feb 25, 2026 · after-hours | Feb 25, 2026 | 56 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | Nov 5, 2025 · after-hours | Nov 5, 2025 | 36 d | 10-Q | — | — | -$1.61 | |
| Q2 2025 | Jun 30, 2025 | Aug 6, 2025 · after-hours | Aug 6, 2025 | 37 d | 10-Q | — | — | -$1.31 | |
| Q1 2025 | Mar 31, 2025 | May 7, 2025 · after-hours | May 7, 2025 | 37 d | 10-Q | — | — | -$1.13 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 26, 2025 · after-hours | Feb 26, 2025 | 57 d | 10-K | $0.00 | −100.0% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 6, 2024 · after-hours | Nov 6, 2024 | 37 d | 10-Q | $0.00 | — | -$0.94 | |
| Q2 2024 | Jun 30, 2024 | Aug 7, 2024 · after-hours | Aug 7, 2024 | 38 d | 10-Q | $0.00 | — | -$0.81 | |
| Q1 2024 | Mar 31, 2024 | May 8, 2024 · after-hours | May 8, 2024 | 38 d | 10-Q | $0.00 | — | -$0.70 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 26, 2024 · after-hours | Feb 26, 2024 | 57 d | 10-K | $742.00K | — | — | |
| Q3 2023 | Sep 30, 2023 | Nov 6, 2023 · after-hours | Nov 6, 2023 | 37 d | 10-Q | $0.00 | — | -$0.99 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022 | Mar 31, 2023 | May 8, 2023 · after-hours | — | — | — | $7.01M | −7.4% | -$0.72 | |
| Q1 2022 | Jun 30, 2022 | Aug 9, 2022 · after-hours | Aug 9, 2022 | 40 d | 10-Q | $9.12M | — | -$0.82 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021 | Mar 31, 2022 | May 9, 2022 · after-hours | — | — | — | $7.58M | — | -$0.78 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020 | Dec 31, 2020 | Mar 2, 2021 · after-hours | Mar 2, 2021 | 61 d | 10-K | $8.75M | −27.6% | -$0.52 | |
| Q3 2020 | Sep 30, 2020 | Nov 12, 2020 · market hours | Nov 12, 2020 | 43 d | 10-Q | $12.66M | +1.2% | -$0.42 | |
| Q2 2020 | Jun 30, 2020 | Aug 10, 2020 · market hours | Aug 10, 2020 | 41 d | 10-Q | $10.03M | −18.4% | -$0.46 | |
| Q1 2020 | Mar 31, 2020 | May 14, 2020 · after-hours | May 14, 2020 | 44 d | 10-Q | $11.55M | −12.3% | -$0.74 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | — | Mar 30, 2020 | 90 d | 10-K | $12.09M | — | -$6.48 | |
| Q3 2019 | Sep 30, 2019 | — | — | — | — | $12.51M | — | -$6.08 | |
| Q2 2019 | Jun 30, 2019 | — | — | — | — | $12.28M | — | -$4.85 | |
| Q1 2019 | Mar 31, 2019 | — | — | — | — | $13.17M | — | -$4.84 | |
